Clinical Genomics Umeå

Infrastructure Unit

Contact

Richard Palmqvist, Platform Scientific Director

richard.palmqvist@umu.se

Linda Köhn, Head of Unit

linda.kohn@umu.se

Recent user publications

The publications in this database are the result of research conducted at the units of SciLifeLab – both in user projects and technology development.

DNA methylation variations and epigenetic aging in telomere biology disorders.

O. Carlund, A. Norberg, P. Osterman, M. Landfors, S. Degerman, M. Hultdin,

Sci Rep13 (1) 7955

Plasma Concentrations of Gut Hormones Acyl Ghrelin and Peptide YY and Subsequent Risk of Colorectal Cancer and Molecular Tumor Subtypes.

S. Bodén, J. Harbs, A. Sundkvist, (…), R. Palmqvist, S. Harlid, B. Van Guelpen,

Cancer Prev Res (Phila)16 (2) 75-87

Immune-Activated B Cells Are Dominant in Prostate Cancer.

A. Saudi, V. Banday, AA. Zirakzadeh, (…), F. Aljabery, O. Winqvist, A. Sherif,

Cancers (Basel)15 (3)

Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer.

T. Lidström, J. Cumming, R. Gaur, (…), M. Dongre, C. Patthey, D. Öhlund,

Cancer Immunol Res11 (1) 72-92
See More
SciLifeLab / Services / Our infrastructure / Clinical Genomics Umeå

Clinical Genomics Umeå

Clinical Genomics Umeå is a joint venture between Umeå University and the clinical laboratories at Umeå University Hospital. It operates in a tight collaboration with Genomic Medicine Center North and is an integrated part of the Department of Medical Biosciences, Umeå University.

Applications

We provide expertise, method development and end-to-end service to translational research and precision diagnostics for the development of tomorrow’s diagnostics. Our current disease focus areas are:

  • Cancers (including solid tumors and hematological malignancies)
  • Rare inherited disease
  • Microbial diseases and surveillance

Services

Our national services within NGS and other molecular technologies include development of methods for clinical implementation or translational research with strong clinical utility. These include, but are not restricted to:

  • Consultation (Project design, Data analysis)
  • QC of samples for various analyses (Sequencing data, Genomic DNA/RNA)
  • Sequencing:
    • DNA sequencing (WGS, WES, Panels, microbial genomes, metagenomics)
  • Other molecular technologies (Array-based analyses, Digital droplet PCR)
  • User access service (DNA/RNA concentration measurements, Automated electrophoresis for DNA/RNA)
  • Bioinformatics ( Software support , Bioinformatic analysis (data generated at CG or elsewhere)
  • Cluster hardware (Support with infrastructure and storage solutions for NGS applications)

Equipments

Our node has access to specialized equipment that enable us to factilitate the translation of new high-throuput techniques into clinical use. These include, but are not restricted to:

  • Various automatic robotic systems ( Beckman i5 Automated Workstation, Myra Liquid Handling Station)
  • Various systems for QC, quantification and fragment analyses (TapeStation, Quantification using fluorescent assay (Qubit, Quantit))
  • Instrumentation for microarray analysis ( HiScan )
  • Instrumentation for Sanger sequencing (ABI3500 xL)
  • Instrumentation for real time PCR and ddPCR (BioRad qPCR, QIAcuity I, ABI QuantStudio 6)
  • Sequencing platforms
    • Illumina (MiSeq, NextSeq 550, NovaSeq X)
    • Nanopore (MinION)
    • Nanostsring (GeoMx, nCounter)

Accessing the Local Unit

For more information about our services, please contact us.

Clinical Genomics

If you do not find the service or technology you require, contact us directly or visit another Clinical Genomics node.

Last updated: 2023-12-07

Content Responsible: admin(website@scilifelab.se)